Back

Early initiation of SGLT2-inhibitors in hospitalized heart failure patients may suppress the decline in physical function

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure (4) Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Yosuke Nishihata

St. Luke's International Hospital, Tokyo (Japan)

3 More presentations in this session

Presentation thumbnail
Usefullness of moncoeur app for HF patients
Doctor E. Berthelot (Le Kremlin-Bicetre, FR)
Abstract Slides Video
Presentation thumbnail
Design and rationale of VN-RAPID: a randomized trial of accelerated guideline-directed medical therapy up-titration in Vietnamese acute heart failure with reduced ejection fraction patients
Mr N. Phan (Ho Chi Minh, VN)
Abstract Slides Video
Presentation thumbnail
The structure of intravenous therapy in patients with acute heart failure: data from a retrospective registry across four regions of Kazakhstan
Doctor G. Yussupova (Aktobe, KZ)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure (4)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Effect of SGLT2-inhibitors on physical function of hospitalized heart failure patients
thumbnail
Congress Presentation
Early in-hospital initiation of SGLT2 inhibitors in acute decompensated heart failure
thumbnail
Congress Presentation
Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: a meta-analysis of randomized controlled trials

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources